Quantum Biopharma (QNTM) Projected to Post Quarterly Earnings on Thursday

Quantum Biopharma (NASDAQ:QNTM) is projected to post its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Quantum Biopharma to post earnings of ($0.80) per share for the quarter.

Quantum Biopharma Price Performance

Shares of QNTM opened at $6.66 on Thursday. Quantum Biopharma has a twelve month low of $2.70 and a twelve month high of $18.00. The firm has a 50 day simple moving average of $5.72. The stock has a market cap of $12.78 million, a price-to-earnings ratio of -0.43 and a beta of 0.37.

Quantum Biopharma Company Profile

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.